Global Autologous Cell Therapy Market By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, and Chondrocytes), By Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, and Wound Healing), By End-User (Hospitals & Clinics, Ambulatory Centers, and Academics & Research), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 99956
- Number of Pages: 341
- Format:
-
-
-
- BrainStorm Cell Therapeutics
- Holostem Terapie Avanzate S.R.L
- Pharmicell Co. Inc
- Opexa Therapeutics
- Caladrius Biosciences Inc.
- S. Stem Cell Inc.
- Lonza Group AG Company Profile
- Bristol Myers Squibb Company Profile
- Novartis AG Company Profile
- Autolus therapeutics
- Tego Science
- Corning Inc.
- Bio Elpida
- Vericel Corporation
- Catalent Inc.
- Sartorius AG
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible